CODX – co-diagnostics, inc. (US:NASDAQ)
Stock Stats
News
Co-Diagnostics (NASDAQ:CODX) was upgraded by analysts at Maxim Group to a "hold" rating.
Co-Diagnostics (NASDAQ:CODX) is now covered by analysts at Maxim Group. They set a "buy" rating and a $1.50 price target on the stock.
Co-Diagnostics (NASDAQ:CODX) had its "neutral" rating reaffirmed by analysts at HC Wainwright.
Co-Diagnostics Delivers Address about Tuberculosis Test Adoption and Implementation at The Union World Conference on Lung Health
Co-Diagnostics Initiates Clinical Evaluations for Upper Respiratory Multiplex Point-of-Care Test on Co-Dx™ PCR Platform to Support Submission to the U.S. FDA
Form 4 Co-Diagnostics, Inc. For: Nov 23 Filed by: Murphy Edward L.
Form 4 Co-Diagnostics, Inc. For: Nov 23 Filed by: Brown Brian Lee
Form 4 Co-Diagnostics, Inc. For: Nov 23 Filed by: SERBIN RICHARD S
Form 4 Co-Diagnostics, Inc. For: Nov 23 Filed by: Abbott Richard David
Form 4 Co-Diagnostics, Inc. For: Nov 23 Filed by: Egan Dwight H
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.